Emerging Areas in Treatment
Researchers are always searching for new and better ways to treat breast cancer.
Advances over the past 40 years have increased survival and improved the quality of life for most people with breast cancer.
Treatments now under study should continue this progress into the future.
Emerging areas in treatment
Learn about new therapies under study in the following areas:
- Radiation therapy for early breast cancer
- Drug therapies for early breast cancer
- Ductal carcinoma in situ (DCIS)
- Metastatic breast cancer
Clinical trials
Research is ongoing to improve all areas of treatment for breast cancer.
New therapies are being studied in clinical trials. The results of these studies will determine whether these therapies become part of the standard of care.
After discussing the benefits and risks with your health care provider, we encourage you to consider joining a clinical trial.
Susan G. Komen® Patient Care Center |
If you or a loved one needs information or resources about clinical trials, the Patient Care Center can help. Contact the Komen Breast Care Helpline at 1-877-465-6636 or email clinicaltrialinfo@komen.org. The Patient Care Center navigators offer breast cancer clinical trial education and support, such as:
Se habla español. |
BreastCancerTrials.org in collaboration with Komen offers a custom matching service to help find clinical trials that fit your needs.
Learn more about clinical trials.
Lajos Pusztai, M.D., D. Phil.
Komen Scholar
“Clinical trials provide a chance to receive tomorrow’s therapies today.”
Our commitment to research |
At Susan G. Komen®, we are committed to saving lives by meeting the most critical needs in our communities and investing in breakthrough research to prevent and cure breast cancer. Our Research Program is an essential driving force for achieving this mission. Since our inception in 1982, Komen has provided funding to support research grants that have greatly expanded our knowledge of breast cancer and helped us understand that breast cancer is not just a single disease but many diseases, unique to each individual. To date, Komen has provided nearly $1.1 billion to researchers in 47 states, the District of Columbia and 24 countries to support research that has resulted in a better understanding of breast cancer; earlier detection; personalized, less invasive treatments for what was once a “one-treatment-fits-all” disease; and improvements in both quality of life and survival rates. Learn more about our continuing investment in research and the exciting research that we are funding, because nothing would make us happier than ending breast cancer forever. |
* Please note, the information provided within Komen Perspectives articles is only current as of the date of posting. Therefore, some information may be out of date.
Updated 04/09/24
